Phillip D. Gray
Impact in
-
- Pharmacological Effects and Toxicity Studies
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 2
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Keith G. Tolman (8 shared papers)Scott K. Kuwada (4 shared papers)R. Tweedale (1 shared paper)Jinqiu Kuang (2 shared papers)Xiufen Li (2 shared papers)P.E. Peterson (1 shared paper)Samuel P. Hammar (1 shared paper)Frederic Clayton (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)International Journal of Cancer (2 papers)The Journal of Clinical Pharmacology (2 papers)Epilepsia (1 paper)The Journal of Cell Biology (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Phillip D. Gray
13 papers receiving 359 citations
Peers
Comparison fields: 5 of 75
- Pediatrics, Perinatology and Child Health 101
- Pharmacology 49
- Immunology and Allergy 22
- Biotechnology 32
- Clinical Biochemistry 23
Countries citing papers authored by Phillip D. Gray
This map shows the geographic impact of Phillip D. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Gray more than expected).
Fields of papers citing papers by Phillip D. Gray
This network shows the impact of papers produced by Phillip D. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Gray. The network helps show where Phillip D. Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip D. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 89 | |
| 2 | 1983 | 69 | |
| 3 | 1978 | 46 | |
| 4 | 2009 | 39 | |
| 5 | 2003 | 39 | |
| 6 | 1984 | 27 | |
| 7 | 1976 | 20 | |
| 8 | Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells. | 1978 | 17 |
| 9 | 1994 | 11 | |
| 10 | 1984 | 11 | |
| 11 | 2011 | 7 | |
| 12 | 1983 | 6 | |
| 13 | 1989 | 4 |
About Phillip D. Gray
Phillip D. Gray is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Oncology, Molecular Biology and Epidemiology, having authored 13 papers that have together received 385 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (4 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Epilepsy research and treatment (2 papers), Digestive system and related health (2 papers), Liver physiology and pathology (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (101 citations), Pharmacology (49 citations), Immunology and Allergy (22 citations), Biotechnology (32 citations) and Clinical Biochemistry (23 citations). Phillip D. Gray has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Keith G. Tolman, Scott K. Kuwada, R. Tweedale, Jinqiu Kuang, Xiufen Li, P.E. Peterson, Samuel P. Hammar, Frederic Clayton, Deborah L. Gumucio and Robert G. Jones. Their work appears in journals such as Biochemical Pharmacology, International Journal of Cancer, The Journal of Clinical Pharmacology, Epilepsia and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.